Rohto Pharmaceutical Co., Ltd. (RPHCF)
15.00
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Rohto Pharmaceutical EPS Diluted (Quarterly) : 0.2918 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2918 |
| March 31, 2026 | 0.154 |
| December 31, 2025 | 0.2908 |
| September 30, 2025 | 0.1691 |
| June 30, 2025 | 0.3555 |
| March 31, 2025 | 0.1744 |
| December 31, 2024 | 0.3391 |
| September 30, 2024 | 0.13 |
| June 30, 2024 | 0.238 |
| March 31, 2024 | 0.1407 |
| December 31, 2023 | 0.2826 |
| September 30, 2023 | 0.2269 |
| June 30, 2023 | 0.2889 |
| March 31, 2023 | 0.1565 |
| December 31, 2022 | 0.261 |
| September 30, 2022 | 0.1958 |
| June 30, 2022 | 0.2354 |
| March 31, 2022 | 0.1509 |
| December 31, 2021 | 0.234 |
| September 30, 2021 | 0.249 |
| June 30, 2021 | 0.189 |
| March 31, 2021 | 0.2486 |
| December 31, 2020 | 0.2054 |
| September 30, 2020 | 0.1667 |
| June 30, 2020 | 0.071 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1142 |
| December 31, 2019 | 0.2114 |
| September 30, 2019 | 0.2072 |
| June 30, 2019 | 0.0882 |
| March 31, 2019 | -0.0427 |
| December 31, 2018 | 0.1377 |
| September 30, 2018 | 0.152 |
| June 30, 2018 | 0.1377 |
| March 31, 2018 | -0.033 |
| December 31, 2017 | 0.1725 |
| September 30, 2017 | 0.1328 |
| June 30, 2017 | 0.0895 |
| March 31, 2017 | 0.0614 |
| December 31, 2016 | 0.1687 |
| September 30, 2016 | 0.1204 |
| June 30, 2016 | 0.0557 |
| March 31, 2016 | 0.0491 |
| December 31, 2015 | 0.1058 |
| September 30, 2015 | 0.1271 |
| June 30, 2015 | 0.0479 |
| March 31, 2015 | 0.1024 |
| December 31, 2014 | 0.0869 |
| September 30, 2014 | 0.1237 |
| June 30, 2014 | 0.0279 |
| March 31, 2014 | 0.0325 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kao Corp. | 0.0801 |
| Kosé Holdings Corp. | 0.1162 |
| euglena Co., Ltd. | 0.0047 |
| Milbon Co., Ltd. | 0.2764 |
| Mandom Corp. | 0.0703 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 69.33M |
| Revenue (Quarterly) | 574.97M |
| Total Expenses (Quarterly) | 508.13M |
| Enterprise Value | 3.342B |
| Gross Profit Margin (Quarterly) | 55.72% |
| Profit Margin (Quarterly) | 12.06% |
| Earnings Yield | 6.04% |
| Operating Earnings Yield | 7.96% |